Marijuana C-Suite Chronicles: Weekenders CEO Kahlil Lozoraitis Brand-Centric Leadership Philosophy For Success
Kahlil Lozoraitis, Weekenders Cannabis CEO and co-founder stands tall as a beacon of leadership and innovation.
From Wiz Khalifa Collab To Realty TV: Twin Brothers’ Diverse Journey To Stardom
Twin duo THEMXXNLIGHT, Kush & Luv Chandani, had their songs featured by Wiz Khalifa after a 3-hour bus ride to NYC. Their journey from dorm room dreams to the forefront of the music industry has been remarkable.
EXCLUSIVE: Alzamend Neuro Plans To Kickstart Stress Disorder Study With Next-Gen Lithium Product Next Year
Alzamend Neuro Inc (NASDAQ: ALZN) received a "Study May Proceed" letter from the FDA for the initiation of study AL001-PTSD01, a Phase 2A study of AL001 for
Coca Leaf, Extract, Cocaine & Safe Supply: Grasping Potentials With Sector Incubator’s President Ronan Levy
Serious research is picking up on the potential mental health benefits of coca plant.
Benzinga’s ‘Stock Whisper’ Index: 5 Stocks Investors Secretly Monitor But Don’t Talk About Yet
A weekly look at top trending tickers seeing increased attention from Benzinga users.
Retail Therapy For Year-End Rally? 3 Top Analyst Stock Picks In E-Commerce, Banking
Marc Chaikin suggests retail therapy for year-end rally, but be selective. Loves Etsy, Shopify & Block. Also likes PNC, BK & TFC banks.
‘The Time To Own Gold Is Now’: Greg Weldon Sees Breakout For Bullion
Even close to record highs, Weldon Financial's Greg Weldon sees more room for gold appreciation as dollar falls.
EXCLUSIVE: Fintech Experts Tackle Market Risks, Emerging Trends At Benzinga New York Event
In a compelling panel discussion at Benzinga’s Fintech Deal Day event held in New York this November, industry experts gathered to delve into the complexities of managing market volatility and strategizing effect
US Stocks Falter, Bonds, Dollar Gain, While Bitcoin Soars Past $43,000 On Rising Institutional Interest: What’s Driving Markets Tuesday?
The momentum on Wall Street during Tuesday’s session continues to lack strength as investors carefully scrutinize the most recent economic data.
EXCLUSIVE: Ocean Biomedical Announces Publication of Breast Cancer Research On New Tumor Suppression Pathway for Proprietary Antibody
Ocean Biomedical (NASDAQ: OCEA) announced that its Scientific Co-founder, Jack Elias, co-authored new findings in the peer-reviewed journal Immunity that detail the mechanisms behind the role of chitinase 3-like-1 (CHI3L1) in the growth of triple-negative breast cancer.